{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:16:54Z","timestamp":1788466614324,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.chest.2022.09.019","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T11:03:23Z","timestamp":1663931003000},"page":"567-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock"],"prefix":"10.1016","volume":"163","author":[{"given":"Bijan","family":"Teja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Walkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.chest.2022.09.019_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2022.09.019_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.chest.2022.04.147","article-title":"Comparison of heart rate after phenylephrine vs norepinephrine initiation in patients with septic shock and atrial fibrillation","volume":"162","author":"Law","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.09.019_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-017-5016-5","article-title":"Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock","volume":"44","author":"Lamontagne","year":"2018","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.chest.2022.09.019_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12630-017-0877-1","article-title":"A\u00a0systematic review of vasopressor blood pressure targets in critically ill adults with hypotension","volume":"64","author":"Hylands","year":"2017","journal-title":"Can J Anaesth"},{"issue":"10","key":"10.1016\/j.chest.2022.09.019_bib6","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.chest.2022.09.019_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/1742-6723.13406","article-title":"Safety of peripheral administration of vasopressor medications: a systematic review","volume":"32","author":"Tian","year":"2020","journal-title":"Emerg Med Australas"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2394","article-title":"Safety of peripheral intravenous administration of vasoactive medication","volume":"10","author":"Cardenas-Garcia","year":"2015","journal-title":"J\u00a0Hosp Med"},{"issue":"2","key":"10.1016\/j.chest.2022.09.019_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1742-6723.13394","article-title":"Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study","volume":"32","author":"Delaney","year":"2020","journal-title":"Emerg Med Australas"},{"issue":"18","key":"10.1016\/j.chest.2022.09.019_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs\u00a0catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2022.09.019_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.chest.2022.09.019_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs\u00a0norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2022.09.019_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2022.09.019_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1073\/pnas.1210200110","article-title":"Endothelial glucocorticoid receptor is required for protection against sepsis","volume":"110","author":"Goodwin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2022.09.019_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.chest.2022.09.019_bib18","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.chest.2022.09.019_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29050","article-title":"Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis (RECORDS) Collaborators. Assessment of machine learning to estimate the individual treatment effect of corticosteroids in septic shock","volume":"3","author":"Pirracchio","year":"2020","journal-title":"JAMA Network Open"},{"issue":"7","key":"10.1016\/j.chest.2022.09.019_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2022.09.019_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2022.09.019_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.chest.2022.09.019_bib24","series-title":"Goodman & Gilman\u2019s Pharmacological Basis of Therapeutics","author":"Louis","year":"2011"},{"key":"10.1016\/j.chest.2022.09.019_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.chest.2022.09.019_bib26","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/CCM.0000000000003889","article-title":"Why my steroid trials in septic shock were \u201cpositive","volume":"47","author":"Annane","year":"2019","journal-title":"Critical Care Med"},{"key":"10.1016\/j.chest.2022.09.019_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.08.038","article-title":"Abrupt versus gradual cessation of steroids in patients with septic shock","volume":"48","author":"Sobolewski","year":"2018","journal-title":"J\u00a0Crit Care"},{"issue":"4","key":"10.1016\/j.chest.2022.09.019_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and hemodynamic effects of \u201clow-dose\u201d hydrocortisone in septic shock","volume":"167","author":"Keh","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2022.09.019_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"issue":"10","key":"10.1016\/j.chest.2022.09.019_bib30","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2022.09.019_bib31","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.09.019_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00134-021-06558-0","article-title":"Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis","volume":"48","author":"Fujii","year":"2022","journal-title":"Intensive Care Med"},{"issue":"25","key":"10.1016\/j.chest.2022.09.019_bib33","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","article-title":"Intravenous vitamin C in adults with sepsis in the intensive care unit","volume":"386","author":"Lamontagne","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2022.09.019_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","article-title":"Vasopressin and its analogues in shock states: a review","volume":"10","author":"Demiselle","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.chest.2022.09.019_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"Norepinephrine: not too much, too long","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.chest.2022.09.019_bib36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.12-1106","article-title":"Survival after shock requiring high-dose vasopressor therapy","volume":"143","author":"Brown","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.09.019_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.chest.2022.09.019_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bja\/aen017","article-title":"Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study","volume":"100","author":"Morelli","year":"2008","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.chest.2022.09.019_bib39","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/00003246-199810000-00014","article-title":"Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients","volume":"26","author":"Dorman","year":"1998","journal-title":"Crit Care Med"},{"issue":"10141","key":"10.1016\/j.chest.2022.09.019_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chest.2022.09.019_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.CIR.3.6.801","article-title":"The influence of respiratory gas mixtures on arterial pressure and vascular reactivity in normal and hypertensive dogs","volume":"3","author":"Page","year":"1951","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.chest.2022.09.019_bib42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1378\/chest.108.5.1373","article-title":"Effect of pH and lidocaine on beta-adrenergic receptor binding. Interaction during resuscitation?","volume":"108","author":"Modest","year":"1995","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2022.09.019_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/0885066617714209","article-title":"Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock","volume":"34","author":"Hammond","year":"2019","journal-title":"J\u00a0Intensive Care Med"},{"issue":"9","key":"10.1016\/j.chest.2022.09.019_bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0885066617716396","article-title":"Hemodynamic instability secondary to vasopressin withdrawal in septic shock","volume":"34","author":"Bissell","year":"2019","journal-title":"J\u00a0Intensive Care Med"},{"issue":"2","key":"10.1016\/j.chest.2022.09.019_bib45","doi-asserted-by":"crossref","first-page":"362.e367","DOI":"10.1016\/j.jcrc.2009.10.005","article-title":"Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study","volume":"25","author":"Bauer","year":"2010","journal-title":"J\u00a0Crit Care"},{"issue":"8","key":"10.1016\/j.chest.2022.09.019_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1060028018765187","article-title":"Evaluating vasopressor discontinuation strategies in patients with septic shock on concomitant norepinephrine and vasopressin infusions","volume":"52","author":"Musallam","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.chest.2022.09.019_bib47","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"Santer","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.chest.2022.09.019_bib48","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1097\/CCM.0000000000003814","article-title":"Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: a single-center retrospective study","volume":"47","author":"Rizvi","year":"2019","journal-title":"Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222038879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222038879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:48:59Z","timestamp":1757926139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222038879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0012369222038879"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.09.019","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}